Diagnostic Value of Superparamagnetic Iron Oxide Nanoparticles as a Tracer for Sentinel Lymph Node Mapping in Early-Stage Cervical Cancer: The Preliminary Clinical Experience
Source abstract
Abstract
Sentinel lymph node (SLN) mapping has been investigated as part of surgical staging in women with early-stage cervical cancer (CC); however, pelvic lymphadenectomy (PLND) remains the standard of care. This study aimed to assess feasibility and safety of SLN detection using superparamagnetic iron oxide (SPIO) nanoparticles as a tracer in CC. Thirty CC patients presumed to be stage I were included in this study with SPIO administered intracervically as a tracer for SLN mapping using a magnetometer and followed by PLND. The endpoints of the study included the proportion of successful SLN detection, the average number of SLNs per patient, and the proportion of pathologically positive results per patient and per node. The diagnostic accuracy of SPIO nanoparticles for detection of metastatic SLNs was evaluated by Receiver Operating Characteristic (ROC) curve analysis, with the area under the ROC curve (AUC) used to demonstrate the studied method’s sensitivity. Safety endpoints were a summary of all reported adverse events. SLNs were detected in all cases, bilaterally in 27 patients (90%). The median number of SLNs per patient was 3.5. Four cases had metastatic SLNs. The general malignancy rate per patient was 13.3%, and per node, it was 0.8%. The malignancy detection rate of SLNs was 100% per patient and 80% per node. The AUC of 1.0 (p < 0.001) confirmed the diagnostic value of the SPIO technique for the detection of metastatic SLNs, with a sensitivity of 100%. No adverse events related to the SPIO administration were reported. SPIO nanoparticles, as a tracer for SLN mapping in early-stage CC patients, demonstrated satisfactory accuracy parameters and safety; however, these data need to be evaluated by further research.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Endometrial and Cervical Cancer Treatments · Cervical Cancer and HPV Research · Ovarian cancer diagnosis and treatment
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Oncology, Faculty of Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland
Department of Oncologic Gynecology, Lower Silesian Oncology, Hematology and Pulmonology Center, 53-413 Wroclaw, Poland
Breast Cancer Clinic, Lower Silesian Oncology, Hematology and Pulmonology Center, 53-413 Wroclaw, Poland
Funding
Polish Ministry of Health · Sysmex Europe GmBH, Norderstedt, Germany
References (46)
Show source-provided references
1. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries10.3322/caac.21834 ↗
2. (2025, March 10). Polish Cancer Registry. Available online: https://onkologia.org.pl.
3. Margioula-Siarkou, C., Almperis, A., Gullo, G., Almperi, E.A., Margioula-Siarkou, G., Nixarlidou, E., Mponiou, K., Papakotoulas, P., Sardeli, C., and Guyon, F. (2023). Sentinel Lymph Node Staging in Early-Stage Cervical Cancer: A Comprehensive Review. J. Clin. Med., 13.10.20944/preprints202310.0828.v1 ↗
4. Impact of micrometastasis or isolated tumor cells on recurrence and survival in patients with early cervical cancer: SENTICOL Trial10.1136/ijgc-2018-000089 ↗
5. Revised FIGO staging for carcinoma of the cervix uteri10.1002/ijgo.12749 ↗
6. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix10.1016/0090-8258(89)90598-2 ↗
7. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer10.1016/j.ygyno.2017.02.005 ↗
8. Sentinel lymph node evaluation in women with cervical cancer10.1016/j.jmig.2013.12.095 ↗
9. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy10.1200/JCO.2002.20.3.688 ↗
10. Long-standing complications after treatment for cancer of the uterine cervix—Clinical significance of medical examination at 5 years after treatment
11. Lower limb lymphedema and neurological complications after lymphadenectomy for gynecological cancer10.1097/IGC.0000000000000341 ↗
12. Sentinel lymph node assessment in endometrial cancer: A systematic review and meta-analysis10.1016/j.ajog.2016.11.1033 ↗
13. Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questions10.1016/j.ygyno.2018.10.007 ↗
14. Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer: The SENTIX trial10.1016/j.ejca.2020.06.034 ↗
15. Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer: Results of a multicentrerandomised trial (SENTICOL-2)10.1016/j.ejca.2021.02.009 ↗
16. SENTICOL III: An international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study10.1136/ijgc-2019-000332 ↗
17. A prospective multicenter trial on sentinel lymph node biopsy in patients with early-stage cervical cancer (SENTIX)10.1136/ijgc-2018-000010 ↗
18. Combining Indocyanine Green and Tc99-nanocolloid does not increase the detection rate of sentinel lymph nodes in earlystage cervical cancer compared to Indocyanine Green alone10.1016/j.ygyno.2019.11.026 ↗
19. The new (Version 9) American Joint Committee on Cancer tumor, node, metastasis staging for cervical cancer10.3322/caac.21663 ↗
20. The Central-European SentiMag study: Sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope10.1016/j.breast.2014.01.004 ↗
21. SentiMAG Trialists Group. Sentinel node biopsy using a magnetic tracer versus standard technique: The SentiMAGMulticentre Trial10.1245/s10434-013-3379-6 ↗
22. Magnetic resonance sentinel lymph node imaging and magnetometer-guided intraoperative detection in prostate cancer using superparamagnetic iron oxide nanoparticles10.2147/IJN.S173182 ↗
23. Sentinel lymph node biopsy in patients with breast cancer using superparamagnetic iron oxide and a magnetometer10.1007/s12282-011-0327-9 ↗
24. The superparamagnetic iron oxide is equivalent to the Tc99 radiotracer method for identifying the sentinel lymph node in breast cancer10.1016/j.ejso.2014.11.006 ↗
25. Sentinel lymph node identification using superparamagnetic iron oxide particles versus radioisotope: The French Sentimag feasibility trial10.1002/jso.24164 ↗
26. Winter, A., Engels, S., Goos, P., Süykers, M.C., Gudenkauf, S., Henke, R.P., and Wawroschek, F. (2019). Accuracy of Magnetometer-Guided Sentinel Lymphadenectomy after Intraprostatic Injection of Superparamagnetic Iron Oxide Nanoparticles in Prostate Cancer: The SentiMag Pro II Study. Cancers, 12.10.20944/preprints201911.0017.v1 ↗
27. Jedryka, M.A., Klimczak, P., Kryszpin, M., Poprawski, T., Czekanski, A., Lepka, P., and Matkowski, R. (2025). Superparamagnetic Iron Oxide Nanoparticles as a Tracer for Sentinel Lymph Node Mapping in Endometrial Cancer. Int. J. Mol. Sci., 26.10.3390/ijms26020781 ↗
28. Superparamagnetic iron oxide: A novel tracer for sentinel lymph node detection in vulvar cancer10.1136/ijgc-2020-001458 ↗
29. Superparamagnetic iron oxide (SPIO) for sentinel lymph node detection in vulvar cancer
30. Murakami, K., Kotani, Y., Suzuki, A., Takaya, H., Nakai, H., Matsuki, M., Sato, T., Mandai, M., and Matsumura, N. (2020). Superparamagnetic iron oxide as a tracer for sentinel lymph node detection in uterine cancer: A pilot study. Sci. Rep., 10.10.1038/s41598-020-64926-0 ↗
31. National Comprehensive Cancer Network (2025, April 18). Cervical cancer Version 4.2025. Available online: https://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf.
32. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer—Update 202310.1136/ijgc-2023-004429 ↗
33. (2025, January 10). Magtrace® Product Brochure. Available online: https://www.endomag.com/resources/downloads/magtrace/?product=magtrace.
34. Cousins, A., Balalis, G.L., Thompson, S.K., Forero Morales, D., Mohtar, A., Wedding, A.B., and Thierry, B. (2015). Novel handheld magnetometer probe based on magnetic tunneling junction sensors for intraoperative sentinel lymph node identification. Sci. Rep., 5.10.1038/srep10842 ↗
35. Amercican Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer10.1200/JCO.2005.08.001 ↗
36. Value of sentinel node mapping in cancer of the cervix10.1016/j.ygyno.2011.04.002 ↗
37. Current status of sentinel lymph node mapping in the management of cervical cancer10.1586/14737140.2013.811147 ↗
38. Robotically assisted fluorescence-guided lymph node mapping with ICG for gynecologic malignancies: A feasibility study10.1016/j.ygyno.2011.09.025 ↗
39. Similar distribution of pelvic sentinel lymph nodes and nodal metastases in cervical and endometrial cancer. A prospective study based on lymphatic anatomy10.1016/j.ygyno.2022.03.027 ↗
40. Consensus on surgical technique for sentinel lymph node dissection in cervical cancer10.1136/ijgc-2023-005151 ↗
41. Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: Results of the SENTICOL study10.1200/JCO.2010.32.0432 ↗
42. Risk factors for failure of bilateral sentinel lymph node mapping in early-stage cervical cancer10.1016/j.ygyno.2019.10.027 ↗
43. Bilateral ultrastaging of sentinel lymph node in cervical cancer: Lowering the false-negative rate and improving the detection of micrometastasis10.1016/j.ygyno.2012.08.035 ↗
44. The sentinel node procedure in early stage cervical cancer, taking the next step; a diagnostic review10.1016/j.ygyno.2015.09.076 ↗
45. Levenback, C.E., van der Zee, A.G.J., and Coleman, R.L. (2022). Sentinel lymph node mapping in cervical cancer. Clinical Lymphatic Mapping in Gynecologic Cancers, Taylor & Francis Group. [2nd ed.].10.1201/9781003255536 ↗
46. Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer10.1056/NEJMoa1806395 ↗